Alpa Laboratories Limited (NSE:ALPA)
69.70
-1.72 (-2.41%)
Jun 1, 2026, 3:29 PM IST
Alpa Laboratories Revenue
In the fiscal year ending March 31, 2026, Alpa Laboratories had annual revenue of 1.22B INR with 8.11% growth. Alpa Laboratories had revenue of 312.37M in the quarter ending March 31, 2026, a decrease of -21.75%.
Revenue
1.22B
Revenue Growth
+8.11%
P/S Ratio
1.21
Revenue / Employee
2.68M
Employees
453
Market Cap
1.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.22B | 91.15M | 8.11% |
| Mar 31, 2025 | 1.12B | 37.13M | 3.41% |
| Mar 31, 2024 | 1.09B | 157.84M | 16.98% |
| Mar 31, 2023 | 929.55M | -193.11M | -17.20% |
| Mar 31, 2022 | 1.12B | 147.12M | 15.08% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nectar Lifesciences | 16.70B |
| Ind-Swift Laboratories | 6.88B |
| Sigachi Industries | 4.85B |
| Balaxi Pharmaceuticals | 2.73B |
| Valiant Laboratories | 2.37B |
| Bafna Pharmaceuticals | 1.47B |
| Vaishali Pharma | 1.14B |
| Par Drugs and Chemicals | 1.08B |